Sartorius 2025r. Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Sartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing In 2025, Sartorius will continue its organic debt reduction course with a focus on working capital and managing investments
Sartorius Aktie Leichter Kursrückgang trotz stabiler Position () aktiencheck.de from www.aktiencheck.de
1 Sartorius publishes alternative performance measures that are not defined by international accounting standards. The SLAS Europe 2025 Conference and Exhibition will bring together the European life sciences and laboratory technology community in Hamburg, from May 20-22, 2025.
Sartorius Aktie Leichter Kursrückgang trotz stabiler Position () aktiencheck.de
Visit SLAS Europe 2025 Conference & Exhibition and discover the latest products in Sartorius BioA portfolio! Sartorius will showcase the latest innovations in BioA technology at booth 1001 As of February 09, 2024, Sartorius AG held around 71.5% of the shares of Sartorius Stedim Biotech S.A The company will provide a quantitative forecast after the first quarter of 2025
2025r. 1 Sartorius publishes alternative performance measures that are not defined by international accounting standards. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment
SARTORIUS LE2202S Weegschaal Troostwijk. Minisart ® RC is optimized for aqueous liquids as well as solvents and is stable against DMSO, other amides, ketones, esters and ethers Minisart ® NY is exceptionally pure compared to other common polyamide (=nylon) filters and competitor products.